Recent Advancements and Future Directions in Diabetes Treatment

In this course, Jessica Wilson, M.D., reviews new and upcoming therapies for diabetes mellitus. 

Commercial Supporter

Baptist Health gratefully acknowledges the educational grant provided by Mannkind and DexCom.

Target Audience

Internal Medicine Physicians, Family Medicine Physicians, Obstetricians, Hospitalists, Fellows, Physician Assistants/Physician Associates, Residents, Advanced Practice Registered Nurses, Nurses, Clinical Laboratory Personnel, Pharmacists, Pharmacy Technicians and all other interested healthcare providers.

Learning Objectives

  • Analyze information from the latest diabetes guidelines.
  • Discuss screening for type 1 diabetes.
  • Review recent medication and device updates.
  • Identify clinical trials underway.
  • Discuss future directions and precision medicine.
Additional information
Bibliography: 
  • Gokalani, R., Saiyed, M., Dey, A., & Sheikh, F. (2024). Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review. Preventive Medicine: Research & Reviews, 1(5), 268-272.
  • Chatterjee, S., & Davies, M. J. (2015). Current management of diabetes mellitus and future directions in care. Postgraduate medical journal, 91(1081), 612-621.
  • Ansari, M. A., Chauhan, W., Shoaib, S., Alyahya, S. A., Ali, M., Ashraf, H., ... & Al-Suhaimi, E. A.(2023). Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions. International Journal of Obesity, 47(12), 1179-1199.
     
Course Summary
Available credit: 
  • 1.00 ABIM Medical Knowledge
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Laboratory Personnel
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy
Course opens: 
09/01/2025
Course expires: 
08/31/2027

Faculty

Jessica R. Wilson, M.D., MSCI
Consultant, Mayo Clinic Florida 
Division of Diabetes Endocrinology and Metabolism

Jessica R. Wilson, M.D., MSCI, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Non-faculty contributors, Boca Raton Regional Hospital internal medicine CME planning committee members, and others involved in the planning, development, and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.

Relevant Financial Relationships

The following individuals involved in the planning, development, review, presentation, authoring and/or editing of the symposium content have disclosed relevant financial relationships with ineligible companies*, and the CME Department has mitigated these potential conflicts of interest. **Indicates that this individual’s presentation(s) will include discussion of off-label or unapproved product usage.

G. Peter Gliebus, M.D., faculty for this educational activity, is on the speaker’s bureau for Eisai. 
Donald Heiman, M.D., faculty for this educational activity, is a shareholder for Abbvie, Bristol Myers Squibb, Johnson & Johnson, and Oramed. 
Marc S. Richards, M.D., faculty for this educational activity, is on the speaker’s bureau for Amgen, Calliditas Therapeutics AB, and Travere Therapeutics, Inc. 

All relevant financial relationships have been mitigated.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Available Credit

  • 1.00 ABIM Medical Knowledge
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Laboratory Personnel
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Pharmacy
Please login or register for a Baptist Health CME account to take this course.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome
Microsoft Edge
Microsoft Edge
Safari
Safari
Moxilla Firefox
Mozilla Firefox
Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to [email protected] and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.